Naloxone Hydrochloride
Who holds supplier records for Naloxone Hydrochloride? 6 organisations hold a current record for Naloxone Hydrochloride: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: United States (1), Netherlands (1), Slovakia (1) and Germany (1); not recorded for 2.
Most records are filed under another form of this substance: Naloxone Hydrochloride Dihydrate (11 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Naloxone Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/naloxone-hydrochloride
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Naloxone Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- NORAMCO INCUnited StatesActive DMF 24633, 43051 · latest filing Jan 2026
- ASPEN OSS BVNetherlands Company GMP cert on recordActive DMF 14034 · latest filing Mar 1999
- FRANCOPIAActive DMF 23142 · latest filing Sept 2009
- MACFARLAN SMITH LTDCompany GMP cert on recordActive DMF 20745 · latest filing Jul 2007
- SANECA PHARMACEUTICALS ASSlovakia Company GMP cert on recordActive DMF 43582 · latest filing Jun 2026
- SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany Company GMP cert on recordActive DMF 34216 · latest filing Oct 2019
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Naloxone Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- EXTAL PTY LTD DIV JOHNSON AND JOHNSONInactive DMF 7138 · filed Sept 1987
- SANOFI AVENTIS CHIMIEInactive DMF 4652 · filed Aug 1982
- DIOSYNTH BVInactive DMF 4595 · filed Jun 1982
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Naloxone Hydrochloride is an opioid antagonist used for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. It blocks or reverses the effects of opioid medication, including extreme drowsiness, slowed breathing, or loss of consciousness.
Chemical identity
- IUPAC name
- (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
- Canonical SMILES
- C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O.Cl
- InChIKey
- RGPDIGOSVORSAK-STHHAXOLSA-N
- Synonyms
- Narcan API, anhydrous naloxone hydrochloride, en-15304, evzio, kloxxado, naloxone hcl, naloxone hydrochloride anhydrous, naloxoni hydrochloridum anhydrous, narcan, narcanti, nih 7890, nsc-757109
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Opioid Antagonist
- Mechanism of action
- Opioid Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Naloxone Hydrochloride?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Naloxone Hydrochloride: NORAMCO INC (United States), ASPEN OSS BV (Netherlands), FRANCOPIA, MACFARLAN SMITH LTD, SANECA PHARMACEUTICALS AS (Slovakia) and SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (Germany). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Naloxone Hydrochloride Drug Master Files are active?
NORAMCO INC (DMF 24633, 43051), ASPEN OSS BV (DMF 14034), FRANCOPIA (DMF 23142), MACFARLAN SMITH LTD (DMF 20745), SANECA PHARMACEUTICALS AS (DMF 43582) and SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (DMF 34216). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Naloxone Hydrochloride records mean?
3 organisations have only inactive Type II DMFs for Naloxone Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Naloxone Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Naloxone Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.